Quality of Recovery After Primary Breast Cancer Surgery: A Randomized, Two-Centre, Triple-Blinded Trial Comparing Erector Spinae Plane Block and Intravenous Lidocaine Infusion Within a Multimodal Analgesia Framework
In brief
Recovery scores were similar with lidocaine or nerve block after breast surgery
In this 80-patient trial, 24-hour recovery scores were nearly identical after intravenous lidocaine or an erector spinae plane block, alongside standardized multimodal pain care. Pain and analgesic needs were also similarly low, with no related adverse events observed. The results support lidocaine as a practical option when block expertise is limited, but do not establish the treatments as equivalent.
- Journal
- Anesthesiology (Q1)
- Published
- 10 November 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Ranjith Kumar Sivakumar, Wei Xiong, Chayapa Luckanachanthachote, Yuxiao Liu, Hoi Ling Wong, Jinyu Wu, et al.
- PMID
- 43006814
- DOI
- 10.1097/ALN.0000000000006476
Why clinicians should know about it
- Picked for Breast and Endocrine Surgery (top studies of the week, 15 November 2026): Randomized comparison of analgesia strategies for breast cancer surgery
Abstract
BACKGROUND: The erector spinae plane block (ESPB) is widely used for primary breast cancer surgery (BCS), though its clinical benefits within optimized multimodal analgesia pathways remain uncertain. Intravenous lidocaine infusion (IVLI) offers a simple, reproducible alternative with potential systemic analgesic effects. This randomized, tripleblinded, placebo controlled, twocentre trial compared the quality of recovery after ESPB versus IVLI for BCS. METHODS: Eighty adult patients undergoing primary BCS, with or without axillary dissection, were randomized to receive either ultrasoundguided ESPB (n=40) or intraoperative IVLI (n=40), in addition to a standardized multimodal analgesic protocol. The primary outcome was quality of recovery (QoR15) score at 24 hours. Secondary outcomes included postoperative pain scores, opioid consumption, adverse events, and rescue analgesia requirements. RESULTS: Both interventions produced excellent postoperative recovery, with 24hour QoR15 scores approaching preoperative baselines with no significant difference between groups (mean (SD) 24-hour QoR score; ESPB vs. IVLI group, 137.7(17.9) vs. 136.3(8.8), p=0.61). Pain burden and analgesic requirements over the first 24 hours were similarly low, and no ESPB or lidocainerelated adverse events were observed. CONCLUSIONS: Within a standardized multimodal analgesic framework, postoperative recovery and analgesic outcomes did not differ significantly between IVLI and ESPB, suggesting that IVLI may offer a pragmatic alternative when regional anesthesia expertise is limited.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.